Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 20, Issue 1, 2002, Pages 35-43

  McKenna, F ^a   Arguelles, L ^a   Burke, T ^a   Lefkowith, J ^a   Geis, G S ^a  

^a TRAFFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

Arthritis; Celecoxib; Tolerability; Upper gastrointestinal tract

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIRHEUMATIC AGENT; ANTIULCER AGENT; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; MALE; NAUSEA; NONBIOLOGICAL MODEL; OSTEOARTHRITIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; UPPER GASTROINTESTINAL TRACT;

ABDOMINAL PAIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DICLOFENAC; DYSPEPSIA; HUMANS; INCIDENCE; OSTEOARTHRITIS; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS; SULFONAMIDES;

EID: 0036193560     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The risks and costs of upper gastrointestinal disease attributable to NSAIDs
2. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs
3. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs
4. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
5. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
6. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
7. Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
8. The importance of gastrointestinal (GI) symptom severity in rheumatoid and osteoarthritis: Symptom rates and risk for GI hospitalization
9. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
10. Recent considerations in non-steroidal anti-inflammatory drug gastropathy
11. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial
12. NSAID induced gastrointestinal complications: The ARAMIS perspective-1997: Arthritis, Rheumatism, and Aging Medical Information System
13. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or the hip: A randomised, placebo controlled trial
14. Do NSAIDs cause dyspepsia: A meta-analysis evaluating alternative definitions
15. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compares to naproxen and placebo
16. Patterns of interchange in the dispensing of non-steroidal anti-inflammatory drugs
17. Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: How physicians manage treatment failures
18. Management of NSAID-related dyspepsia in the community
19. Synthesis an biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl) benzenesulfonamide (SC-58635, celecoxib)
20. Celecoxib versus diclofenac in the management of osteoarthritis of the knee - Placebo-controlled, randomised, double-blind comparison
21. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial
22. The anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
23. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
24. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor
25. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
26. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
27. The American College of Rheumatology criteria for classification and reporting of osteoarthritis of the hip
28. Therapeutic criteria in rheumatoid arthritis
29. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
30. Methods for pooled analyses of epidemiologic studies
31. The shadow costs of NSAID therapy: A population-based cohort study
32. Gastrointestinal health care resource use and costs associated with nonsteroidal anti-inflammatory drugs versus acetaminophen
33. Cost of NSAID adverse effects to the UK National Health Service